Garrick Kenneth PACKARD

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
ASGPR cell surface receptor binding compounds and conjugates
- Patent number 12,258,332
- Issue date Mar 25, 2025
- Lycia Therapeutics, Inc.
- Brett Bradley Busch
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
EIF4A-inhibiting compounds and methods related thereto
- Patent number 11,440,917
- Issue date Sep 13, 2022
- eFFECTOR THERAPEUTICS, INC.
- Justin T. Ernst
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
- Patent number 11,292,796
- Issue date Apr 5, 2022
- Signal Pharmaceuticals, LLC
- Jan Elsner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
EIF4E-inhibiting compounds and methods
- Patent number 11,286,268
- Issue date Mar 29, 2022
- eFFECTOR THERAPEUTICS, INC.
- Samuel Sperry
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
- Patent number 10,683,298
- Issue date Jun 16, 2020
- Signal Pharmaceuticals, LLC
- Jan Elsner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
EIF4A-inhibiting compounds and methods related thereto
- Patent number 10,577,378
- Issue date Mar 3, 2020
- eFFECTOR THERAPEUTICS, INC.
- Justin T. Ernst
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
- Patent number 10,167,290
- Issue date Jan 1, 2019
- Signal Pharmaceuticals, LLC
- Jan Elsner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
eIF4A-inhibiting compounds and methods related thereto
- Patent number 9,957,277
- Issue date May 1, 2018
- eFFECTOR THERAPEUTICS, INC.
- Justin T. Ernst
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
- Patent number 9,771,371
- Issue date Sep 26, 2017
- Signal Pharmaceuticals, LLC
- Jan Elsner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Halogen substituted pyrazines as intermediates of mTOR kinase inhib...
- Patent number 9,193,692
- Issue date Nov 24, 2015
- Signal Pharmaceuticals, LLC
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of synthesis and purification of heteroaryl compounds
- Patent number 9,079,900
- Issue date Jul 14, 2015
- Signal Pharmaceuticals, LLC
- Roy L. Harris
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
- Patent number 8,907,087
- Issue date Dec 9, 2014
- Signal Pharmaceuticals, LLC
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of synthesis and purification of heteroaryl compounds
- Patent number 8,569,494
- Issue date Oct 29, 2013
- Signal Pharmaceuticals, LLC
- Roy L. Harris
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indicati...
- Patent number 8,507,492
- Issue date Aug 13, 2013
- Signal Pharmaceuticals, LLC
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indicati...
- Patent number 8,492,381
- Issue date Jul 23, 2013
- Signal Pharmaceuticals, LLC
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treatment comprising the administration of heteroaryl co...
- Patent number 8,372,976
- Issue date Feb 12, 2013
- Signal Pharmaceuticals, LLC
- Deborah Sue Mortensen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aminotriazolopyridines, compositions thereof, and methods of treatm...
- Patent number 8,299,056
- Issue date Oct 30, 2012
- Signal Pharmaceuticals, LLC
- Sogole Bahmanyar
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indicat...
- Patent number 8,110,578
- Issue date Feb 7, 2012
- Signal Pharmaceuticals, LLC
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl compounds, compositions thereof, and methods of treatmen...
- Patent number 7,981,893
- Issue date Jul 19, 2011
- Signal Pharmaceuticals, LLC
- Deborah Sue Mortensen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Kinase inhibitors
- Patent number 6,831,175
- Issue date Dec 14, 2004
- Abbott Laboratories
- Qun Li
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ASGPR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES
- Publication number 20250101007
- Publication date Mar 27, 2025
- Lycia Therapeutics, Inc.
- Brett Bradley BUSCH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SIGLEC LIGANDS, CONJUGATES, AND METHODS OF USE THEREOF
- Publication number 20250064941
- Publication date Feb 27, 2025
- Osprey Biopharmaceuticals, Inc.
- Mehdi Numa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
M6PR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES
- Publication number 20240335544
- Publication date Oct 10, 2024
- Lycia Therapeutics, Inc.
- Brett Bradley BUSCH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bifunctional Folate Receptor Binding Compounds
- Publication number 20240165250
- Publication date May 23, 2024
- Lycia Therapeutics, Inc.
- Jason G. Lewis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EIF4A-INHIBITING COMPOUNDS AND METHODS RELATED THERETO
- Publication number 20230295179
- Publication date Sep 21, 2023
- eFFECTOR Therapeutics, Inc.
- Justin T. ERNST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ASGPR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES
- Publication number 20230250091
- Publication date Aug 10, 2023
- Lycia Therapeutics, Inc.
- Brett Bradley BUSCH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREX1 INHIBITORS AND USES THEREOF
- Publication number 20230234943
- Publication date Jul 27, 2023
- Tempest Therapeutics, Inc.
- Thomas Walter DUBENSKY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cell Surface Receptor Binding Compounds and Conjugates
- Publication number 20230158155
- Publication date May 25, 2023
- Lycia Therapeutics, Inc.
- Brett Bradley BUSCH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EIF4E-INHIBITING COMPOUNDS AND METHODS
- Publication number 20230108594
- Publication date Apr 6, 2023
- eFFECTOR Therapeutics, Inc.
- Samuel SPERRY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EIF4A-INHIBITING COMPOUNDS AND METHODS RELATED THERETO
- Publication number 20230071483
- Publication date Mar 9, 2023
- eFFECTOR Therapeutics Inc.
- Justin T. ERNST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EIF4A-INHIBITING COMPOUNDS AND METHODS RELATED THERETO
- Publication number 20200339590
- Publication date Oct 29, 2020
- eFector Therapautics, Inc.
- Justin T. Ernst
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...
- Publication number 20200262840
- Publication date Aug 20, 2020
- Signal Pharmaceuticals, LLC.
- Jan ELSNER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...
- Publication number 20190077806
- Publication date Mar 14, 2019
- Signal Pharmaceuticals, LLC.
- Jan ELSNER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EIF4A-INHIBITING COMPOUNDS AND METHODS RELATED THERETO
- Publication number 20180298017
- Publication date Oct 18, 2018
- eFFECTOR Therapeutics, Inc.
- Justin T. ERNST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...
- Publication number 20170342080
- Publication date Nov 30, 2017
- Signal Pharmaceuticals, LLC.
- Jan ELSNER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EIF4A-INHIBITING COMPOUNDS AND METHODS RELATED THERETO
- Publication number 20170145026
- Publication date May 25, 2017
- eFFECTOR Therapeutics, Inc.
- Justin T. ERNST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...
- Publication number 20160024101
- Publication date Jan 28, 2016
- Signal Pharmaceuticals, LLC.
- Jan ELSNER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...
- Publication number 20150051397
- Publication date Feb 19, 2015
- Signal Pharmaceuticals, LLC.
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF SYNTHESIS AND PURIFICATION OF HETEROARYL COMPOUNDS
- Publication number 20140155593
- Publication date Jun 5, 2014
- Signal Pharmaceuticals, LLC.
- Roy L. Harris
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...
- Publication number 20130289271
- Publication date Oct 31, 2013
- Signal Pharmaceuticals, LLC.
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF SYNTHESIS AND PURIFICATION OF HETEROARYL COMPOUNDS
- Publication number 20130245254
- Publication date Sep 19, 2013
- Signal Pharmaceuticals, LLC.
- Roy L. Harris
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMINOTRIAZOLOPYRIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATM...
- Publication number 20130005707
- Publication date Jan 3, 2013
- Sogole Bahmanyar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITOR FOR ONCOLOGY INDICATI...
- Publication number 20120071658
- Publication date Mar 22, 2012
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITOR FOR ONCOLOGY INDICATI...
- Publication number 20120059164
- Publication date Mar 8, 2012
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATMENT COMPRISING THE ADMINISTRATION OF HETEROARYL CO...
- Publication number 20110245245
- Publication date Oct 6, 2011
- Signal Pharmaceuticals, LLC.
- Deborah Sue Mortensen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF SYNTHESIS AND PURIFICATION OF HETEROARYL COMPOUNDS
- Publication number 20110137028
- Publication date Jun 9, 2011
- Roy L. Harris
- C07 - ORGANIC CHEMISTRY
Information Patent Application
mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCI...
- Publication number 20100216781
- Publication date Aug 26, 2010
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMINOTRIAZOLOPYRIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATM...
- Publication number 20100093698
- Publication date Apr 15, 2010
- Sogole Bahmanyar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heteroaryl compounds, compositions thereof, and methods of treatmen...
- Publication number 20090023724
- Publication date Jan 22, 2009
- Deborah Sue Mortensen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of TNFalpha, PDE4 and B-RAF, compositions thereof and me...
- Publication number 20080004271
- Publication date Jan 3, 2008
- Jeffrey M. McKenna
- C07 - ORGANIC CHEMISTRY

Garrick Kenneth PACKARD

Person

Patents Grantslast 30 patents

ASGPR cell surface receptor binding compounds and conjugates

EIF4A-inhibiting compounds and methods related thereto

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

EIF4E-inhibiting compounds and methods

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

EIF4A-inhibiting compounds and methods related thereto

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

eIF4A-inhibiting compounds and methods related thereto

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

Halogen substituted pyrazines as intermediates of mTOR kinase inhib...

Methods of synthesis and purification of heteroaryl compounds

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

Methods of synthesis and purification of heteroaryl compounds

Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indicati...

Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indicati...

Methods of treatment comprising the administration of heteroaryl co...

Aminotriazolopyridines, compositions thereof, and methods of treatm...

Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indicat...

Heteroaryl compounds, compositions thereof, and methods of treatmen...

Kinase inhibitors

Patents Applicationslast 30 patents

ASGPR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES

SIGLEC LIGANDS, CONJUGATES, AND METHODS OF USE THEREOF

M6PR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES

Bifunctional Folate Receptor Binding Compounds

EIF4A-INHIBITING COMPOUNDS AND METHODS RELATED THERETO

ASGPR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES

TREX1 INHIBITORS AND USES THEREOF

Cell Surface Receptor Binding Compounds and Conjugates

EIF4E-INHIBITING COMPOUNDS AND METHODS

EIF4A-INHIBITING COMPOUNDS AND METHODS RELATED THERETO

EIF4A-INHIBITING COMPOUNDS AND METHODS RELATED THERETO

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...

EIF4A-INHIBITING COMPOUNDS AND METHODS RELATED THERETO

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...

EIF4A-INHIBITING COMPOUNDS AND METHODS RELATED THERETO

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...

METHODS OF SYNTHESIS AND PURIFICATION OF HETEROARYL COMPOUNDS

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...

METHODS OF SYNTHESIS AND PURIFICATION OF HETEROARYL COMPOUNDS

AMINOTRIAZOLOPYRIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATM...

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITOR FOR ONCOLOGY INDICATI...

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITOR FOR ONCOLOGY INDICATI...

METHODS OF TREATMENT COMPRISING THE ADMINISTRATION OF HETEROARYL CO...

METHODS OF SYNTHESIS AND PURIFICATION OF HETEROARYL COMPOUNDS

mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCI...

AMINOTRIAZOLOPYRIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATM...

Heteroaryl compounds, compositions thereof, and methods of treatmen...

Inhibitors of TNFalpha, PDE4 and B-RAF, compositions thereof and me...